NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Warren Z, Veenstra-VanderWeele J, Stone W, et al. Therapies for Children With Autism Spectrum Disorders. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Apr. (Comparative Effectiveness Reviews, No. 26.)

Cover of Therapies for Children With Autism Spectrum Disorders

Therapies for Children With Autism Spectrum Disorders.

Show details

References

1.
Prevalence of the Autism Spectrum Disorders (ASDs) in Multiple Areas of the United States, 2004 and 2006. Atlanta: Centers for Disease Control and Prevention; 2009.
2.
Shelton JF, Tancredi DJ, Hertz-Picciotto I. Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res. 2010 Feb;3(1):30–39. [PMC free article: PMC4068119] [PubMed: 20143326]
3.
Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007 Nov;120(5):1183–215. [PubMed: 17967920]
4.
Diagnostic and Statistical Manual of Mental Disorders. IV ed. Washington DC: American Psychiatric Association; 2000.
5.
Zwaigenbaum L, Bryson S, Lord C, et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics. 2009 May;123(5):1383–1391. [PMC free article: PMC2833286] [PubMed: 19403506]
6.
Myers SM, Johnson CP. Management of children with autism spectrum disorders. Pediatrics. 2007 Nov;120(5):1162–1182. [PubMed: 17967921]
7.
Myers SM. Management of autism spectrum disorders in primary care. Pediatr Ann. 2009 Jan;38(1):42–49. [PubMed: 19213293]
8.
Seida JK, Ospina MB, Karkhaneh M, et al. Systematic reviews of psychosocial interventions for autism: an umbrella review. Dev Med Child Neurol. 2009 Feb;51(2):95–104. [PubMed: 19191842]
9.
Ospina MB, Krebs Seida J, Clark B, et al. Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review. PLoS One. 2008;3(11):e3755. [PMC free article: PMC2582449] [PubMed: 19015734]
10.
Parr J. Autism. Clin Evid (Online) 2008 [PubMed: 19450315]
11.
Bryson SE, Rogers SJ, Fombonne E. Autism spectrum disorders: early detection, intervention, education, and psychopharmacological management. Can J Psychiatry. 2003 Sep;48(8):506–516. [PubMed: 14574826]
12.
Rogers SJ, Vismara LA. Evidence-Based Comprehensive Treatments for Early Autism. Journal of Clinical Child and Adolescent Psychology. 2008 Jan;37(1):8–38. [PMC free article: PMC2943764] [PubMed: 18444052]
13.
National Research Council. Committee on Educational Interventions for Children with Autism, Educating Children with Autism. Washington DC: 2001.
14.
National Standards Report Randolph. MA: National Autism Center; 2009.
15.
Howlin P, Magiati I, Charman T. Systematic Review of Early Intensive Behavioral Interventions for Children with Autism. American Journal on Intellectual and Developmental Disabilities. 2009 Jan;114(1):23–41. [PubMed: 19143460]
16.
Baranek GT. Efficacy of sensory and motor interventions for children with autism. J Autism Dev Disord. 2002 Oct;32(5):397–422. [PubMed: 12463517]
17.
Millward C, Ferriter M, Calver S, et al. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev. 2008(2):CD003498. [PMC free article: PMC4164915] [PubMed: 18425890]
18.
Levy S, Kim A-H, Olive ML. Interventions for Young Children with Autism: A Synthesis of the Literature. Focus on Autism and Other Developmental Disabilities. 2006 Spr;21(1):55–62.
19.
Levy SE, Hyman SL. Novel treatments for autistic spectrum disorders. Ment Retard Dev Disabil Res Rev. 2005;11(2):131–142. [PubMed: 15977319]
20.
Aman MG, Langworthy KS. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord. 2000 Oct;30(5):451–459. [PubMed: 11098883]
21.
Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol. 1987 Feb;55(1):3–9. [PubMed: 3571656]
22.
DeMyer MK, Hingtgen JN, Jackson RK. Infantile autism reviewed: a decade of research. Schizophr Bull. 1981;7(3):388–451. [PubMed: 6116276]
23.
Kanner L. Autistic Disturbances of Affective Contact. Nervous Child 2. 1943;1943:217–250.
24.
Rutter M. Diagnosis and definition of childhood autism. J Autism Child Schizophr. 1978 Jun;8(2):139–161. [PubMed: 670129]
25.
Chalfant AM, Rapee R, Carroll L. Treating anxiety disorders in children with high functioning autism spectrum disorders: a controlled trial. J Autism Dev Disord. 2007 Nov;37(10):1842–1857. [PubMed: 17171539]
26.
Reaven JA, Blakeley-Smith A, Nichols S, et al. Cognitive-Behavioral Group Treatment for Anxiety Symptoms in Children with High-Functioning Autism Spectrum Disorders: A Pilot Study. Focus on Autism and Other Developmental Disabilities. 2009;24(1):27–37.
27.
Reaven J, Hepburn S. Cognitive-behavioral treatment of obsessive-compulsive disorder in a child with Asperger syndrome: a case report. Autism. 2003 Jun;7(2):145–164. [PubMed: 12846384]
28.
Muris P, Steerneman P, Merckelbach H, et al. Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Disord. 1998 07-08;12(4):387–393. [PubMed: 9699121]
29.
Kendall PC, editor. Child and adolescent therapy : cognitive-behavioral procedures. New York: Guildford Press; 2005.
30.
Mesibov GSV. The culture of autism: From theoretical understanding to educational practice. University of North Carolina at Chapel Hill: Division TEACCH, Department of Psychiatry; 1998.
31.
Carpenter WT, Koenig JI. The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology. 2008 Aug;33(9):2061–2079. [PMC free article: PMC2575138] [PubMed: 18046305]
32.
Akam E, Strange PG. Inverse agonist properties of atypical antipsychotic drugs. Biochem Pharmacol. 2004 Jun 1;67(11):2039–2045. [PubMed: 15135301]
33.
Meltzer HY, Huang M. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog Brain Res. 2008;172:177–197. [PubMed: 18772033]
34.
Kuroki T, Nagao N, Nakahara T. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Prog Brain Res. 2008;172:199–212. [PubMed: 18772034]
35.
Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry. 2007 Apr;64(4):442–455. [PubMed: 17404121]
36.
Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry. 2009 Sep;166(9):980–91. [PubMed: 19687129]
37.
Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006 Jul;11(7):622–632. [PubMed: 16585942]
38.
Bloch MH. Emerging treatments for Tourette’s disorder. Curr Psychiatry Rep. 2008 Aug;10(4):323–30. [PubMed: 18627671]
39.
Anderson LT, Campbell M, Adams P, et al. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord. 1989 Jun;19(2):227–239. [PubMed: 2663834]
40.
Tatsumi M, Groshan K, Blakely RD, et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997 Dec 11;340(2–3):249–258. [PubMed: 9537821]
41.
Esbensen AJ, Greenberg JS, Seltzer MM, et al. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. J Autism Dev Disord. 2009 Sep;39(9):1339–1349. [PMC free article: PMC2829244] [PubMed: 19434487]
42.
Aman MG, Lam KS, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. J Child Adolesc Psychopharmacol. 2005 Feb;15(1):116–126. [PubMed: 15741793]
43.
Aman MG, Lam KS, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. J Autism Dev Disord. 2003 Oct;33(5):527–534. [PubMed: 14594332]
44.
Gordon CT, Rapoport JL, Hamburger SD, et al. Differential response of seven subjects with autistic disorder to clomipramine and desipramine. Am J Psychiatry. 1992 Mar;149(3):363–366. [PubMed: 1536276]
45.
Cook EH Jr, Rowlett R, Jaselskis C, et al. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry. 1992 Jul;31(4):739–745. [PubMed: 1644739]
46.
Mulder EJ, Anderson GM, Kema IP, et al. Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry. 2004 Apr;43(4):491–499. [PubMed: 15187810]
47.
Gordon CT, State RC, Nelson JE, et al. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry. 1993 Jun;50(6):441–447. [PubMed: 8498878]
48.
McDougle CJ, Naylor ST, Cohen DJ, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 1996 Nov;53(11):1001–1008. [PubMed: 8911223]
49.
Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry. 2006 Mar;67(3):407–414. [PubMed: 16649827]
50.
Jou RJ, Handen BL, Hardan AY. Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2005 Apr;15(2):325–330. [PubMed: 15910217]
51.
Posey DJ, Wiegand RE, Wilkerson J, et al. Open-label atomoxetine for attention-deficit/hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006 Oct;16(5):599–610. [PubMed: 17069548]
52.
Arnold LE, Aman MG, Cook AM, et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry. 2006 Oct;45(10):1196–1205. [PubMed: 17003665]
53.
Scahill L, Aman MG, McDougle CJ, et al. A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006 Oct;16(5):589–598. [PubMed: 17069547]
54.
Handen BL, Sahl R, Hardan AY. Guanfacine in children with autism and/or intellectual disabilities. J Dev Behav Pediatr. 2008 Aug;29(4):303–308. [PubMed: 18552703]
55.
Tulassay Z, Bodnar A, Farkas I, et al. Somatostatin versus secretin in the treatment of actively bleeding gastric erosions. Digestion. 1992;51(4):211–216. [PubMed: 1356864]
56.
Watanabe Y, Tsumura H, Sasaki H. Effect of continuous intravenous infusion of secretin preparation (secrepan) in patients with hemorrhage from chronic peptic ulcer and acute gastric mucosal lesion (AGML) Gastroenterol Jpn. 1991 Jul;26(Suppl 3):86–89. [PubMed: 1884969]
57.
Charlton CG, Miller RL, Crawley JN, et al. Secretin modulation of behavioral and physiological functions in the rat. Peptides. 1983 09-10;4(5):739–742. [PubMed: 6657519]
58.
Fremeau RT Jr, Jensen RT, Charlton CG, et al. Secretin: specific binding to rat brain membranes. J Neurosci. 1983 Aug;3(8):1620–1625. [PubMed: 6308185]
59.
Horvath K, Stefanatos G, Sokolski KN, et al. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys. 1998;9(1):9–15. [PubMed: 9585670]
60.
Cortesi F, Giannotti F, Ivanenko A, et al. Sleep in children with autistic spectrum disorder. Sleep Med. 2010 Aug;11(7):659–664. [PubMed: 20605110]
61.
Zawilska JB, Skene DJ, Arendt J. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep. 2009 05-06;61(3):383–410. [PubMed: 19605939]
62.
Dosman CF, Drmic IE, Brian JA, et al. Ferritin as an indicator of suspected iron deficiency in children with autism spectrum disorder: prevalence of low serum ferritin concentration. Dev Med Child Neurol. 2006 Dec;48(12):1008–1009. [PubMed: 17109795]
63.
Schneider CK, Melmed RD, Barstow LE, et al. Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study. J Autism Dev Disord. 2006 Nov;36(8):1053–1064. [PubMed: 16845577]
64.
Handen BL, Melmed RD, Hansen RL, et al. A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. J Autism Dev Disord. 2009 May;39(5):796–805. [PubMed: 19148734]
65.
Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev. 2005(4):CD003497. [PubMed: 16235322]
66.
Gaby AR. Natural approaches to epilepsy. Altern Med Rev. 2007 Mar;12(1):9–24. [PubMed: 17397265]
67.
Pearl PL, Gibson KM. Clinical aspects of the disorders of GABA metabolism in children. Curr Opin Neurol. 2004 Apr;17(2):107–113. [PubMed: 15021235]
68.
Rossignol DA. Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry. 2009 10-12;21(4):213–236. [PubMed: 19917212]
69.
Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutr J. 2008;7:2. [PMC free article: PMC2248201] [PubMed: 18208598]
70.
Levy R, Cooper P. Ketogenic diet for epilepsy. Cochrane Database Syst Rev. 2003(3):CD001903. [PubMed: 12917915]
71.
Lechin F, van der Dijs B, Pardey-Maldonado B, et al. Effects of amantadine on circulating neurotransmitters in healthy subjects. J Neural Transm. 2010 Mar;117(3):293–299. [PMC free article: PMC2825314] [PubMed: 20131070]
72.
Farlow MR. Treatment of mild cognitive impairment (MCI) Curr Alzheimer Res. 2009 Aug;6(4):362–367. [PubMed: 19689235]
73.
Calvert JW, Cahill J, Zhang JH. Hyperbaric oxygen and cerebral physiology. Neurol Res. 2007 Mar;29(2):132–141. [PubMed: 17439697]
74.
McDonagh MS, Morgan D, Carson S, et al. Systematic review of hyperbaric oxygen therapy for cerebral palsy: the state of the evidence. Dev Med Child Neurol. 2007 Dec;49(12):942–947. [PubMed: 18039243]
75.
Santoro A, Siviero P, Minicuci N, et al. Effects of donepezil, galantamine and rivastigmine in 938 italian patients with Alzheimer’s disease: a prospective, observational study. CNS Drugs. 2010 Feb 1;24(2):163–176. [PubMed: 20088621]
76.
Bradberry S, Vale A. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning. Clin Toxicol (Phila) 2009 Aug;47(7):617–631. [PubMed: 19663612]
77.
Boscolo M, Antonucci S, Volpe AR, et al. Acute mercury intoxication and use of chelating agents. J Biol Regul Homeost Agents. 2009 10-12;23(4):217–223. [PubMed: 20003760]
78.
Kidd PM. Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev. 2002 Dec;7(6):472–99. [PubMed: 12495373]
79.
Gupta S. Immunological treatments for autism. J Autism Dev Disord. 2000 Oct;30(5):475–479. [PubMed: 11098887]
80.
Yoder PJ, Warren SF, Kim K, et al. Facilitating prelinguistic communication skills in young children with developmental delay. II: Systematic replication and extension. J Speech Hear Res. 1994 Aug;37(4):841–851. [PubMed: 7526042]
81.
Warren SF, Yoder PJ, Gazdag GE, et al. Facilitating prelinguistic communication skills in young children with developmental delay. J Speech Hear Res. 1993 Feb;36(1):83–97. [PubMed: 7680733]
82.
Bondy AS, Frost LA. PECS: The Picture Exchange Communication System Training Manual. 1st ed. Cherry Hill, NJ: 1994.
83.
Baron-Cohen S, Ashwin E, Ashwin C, et al. Talent in autism: hyper-systemizing, hyper-attention to detail and sensory hypersensitivity. Philos Trans R Soc Lond B Biol Sci. 2009 May 27;364(1522):1377–1383. [PMC free article: PMC2677592] [PubMed: 19528020]
84.
Rogers SJ, Ozonoff S. Annotation: what do we know about sensory dysfunction in autism? A critical review of the empirical evidence. J Child Psychol Psychiatry. 2005 Dec;46(12):1255–1268. [PubMed: 16313426]
85.
Jean AA. Sensory integration and learning disorders. Los Angeles: Western Psychological Services; 1972.
86.
Sinha Y, Silove N, Wheeler D, et al. Auditory integration training and other sound therapies for autism spectrum disorders. Cochrane Database Syst Rev. 2004(1):CD003681. [PubMed: 14974028]
87.
Sinha Y, Silove N, Wheeler D, et al. Auditory integration training and other sound therapies for autism spectrum disorders: a systematic review. Arch Dis Child. 2006 Dec;91(12):1018–1022. [PMC free article: PMC2082994] [PubMed: 16887860]
88.
Gold C, Wigram T, Elefant C. Music therapy for autistic spectrum disorder. Cochrane Database Syst Rev. 2006(2):CD004381. [PubMed: 16625601]
89.
Kim J, Wigram T, Gold C. Emotional, motivational and interpersonal responsiveness of children with autism in improvisational music therapy. Autism. 2009 Jul;13(4):389–409. [PubMed: 19535468]
90.
Field T, Lasko D, Mundy P, et al. Brief report: autistic children’s attentiveness and responsivity improve after touch therapy. J Autism Dev Disord. 1997 Jun;27(3):333–338. [PubMed: 9229263]
91.
Zwaigenbaum L, Thurm A, Stone W, et al. Studying the Emergence of Autism Spectrum Disorders in High-Risk Infants: Methodological and Practical Issues. Journal of Autism and Developmental Disorders. 2007 Mar;37(3):466–480. [PubMed: 16897376]
92.
American Academy of Pediatrics. The pediatrician’s role in the diagnosis and anagement of autistic spectrum disorder in children. Pediatrics. 2001 May;107(5):1221–1226. [PubMed: 11331713]
93.
Carbone PS, Behl DD, Azor V, et al. The medical home for children with autism spectrum disorders: Parent and pediatrician perspectives. Journal of Autism and Developmental Disorders. 2010 Mar;40(3):317–324. [PubMed: 19768528]
94.
Bent S, Bertoglio K, Hendren RL. Omega-3 Fatty Acids for Autistic Spectrum Disorder: A Systematic Review. Journal of Autism and Developmental Disorders. 2009 Aug;39(8):1145–1154. [PMC free article: PMC2710498] [PubMed: 19333748]
95.
Broadstock M, Doughty C, Eggleston M. Systematic Review of the Effectiveness of Pharmacological Treatments for Adolescents and Adults with Autism Spectrum Disorder. Autism: The International Journal of Research and Practice. 2007;11(4):335–348. [PubMed: 17656398]
96.
Williams KW, Wray JJ, Wheeler DM. Intravenous secretin for autism spectrum disorder. Cochrane Database Syst Rev. 2005(3):CD003495. [PubMed: 16034901]
97.
Horner RHCE, Halle J, McGee G, Odom S, Wolery M. The use of single subject research to identify evidence-based practice in special education. Except Child. 2005;71:165–179.
98.
Chou R, Aronson N, Atkins D, et al. AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol. 2010 May;63(5):502–512. [PubMed: 18823754]
99.
Owens DK, Lohr KN, Atkins D, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. 2010 May;63(5):513–523. [PubMed: 19595577]
100.
Green J, Charman T, McConachie H, et al. Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial. Lancet. 2010 May 20 [PMC free article: PMC2890859] [PubMed: 20494434]
101.
Remington B, Hastings RP, Kovshoff H, et al. Early intensive behavioral intervention: outcomes for children with autism and their parents after two years. Am J Ment Retard. 2007 Nov;112(6):418–438. [PubMed: 17963434]
102.
Ben Itzchak E, Lahat E, Burgin R, et al. Cognitive, behavior and intervention outcome in young children with autism. Res Dev Disabil. 2008 09-10;29(5):447–458. [PubMed: 17923388]
103.
Reed P, Osborne LA, Corness M. Brief report: relative effectiveness of different home-based behavioral approaches to early teaching intervention. J Autism Dev Disord. 2007 Oct;37(9):1815–1821. [PubMed: 17180714]
104.
Ben-Itzchak E, Zachor DA. The effects of intellectual functioning and autism severity on outcome of early behavioral intervention for children with autism. Res Dev Disabil. 2007 05-06;28(3):287–303. [PubMed: 16730944]
105.
Cohen H, Amerine-Dickens M, Smith T. Early intensive behavioral treatment: replication of the UCLA model in a community setting. J Dev Behav Pediatr. 2006 Apr;27(2 Suppl):S145–155. [PubMed: 16685181]
106.
Eldevik S, Eikeseth S, Jahr E, et al. Effects of low-intensity behavioral treatment for children with autism and mental retardation. J Autism Dev Disord. 2006 Feb;36(2):211–224. [PubMed: 16477514]
107.
Beglinger L, Smith T. Concurrent validity of social subtype and IQ after early intensive behavioral intervention in children with autism: a preliminary investigation. J Autism Dev Disord. 2005 Jun;35(3):295–303. [PubMed: 16119470]
108.
Aldred C, Green J, Adams C. A new social communication intervention for children with autism: pilot randomised controlled treatment study suggesting effectiveness. J Child Psychol Psychiatry. 2004 Nov;45(8):1420–1430. [PubMed: 15482502]
109.
Drew A, Baird G, Baron-Cohen S, et al. A pilot randomised control trial of a parent training intervention for pre-school children with autism. Preliminary findings and methodological challenges. Eur Child Adolesc Psychiatry. 2002 Dec;11(6):266–272. [PubMed: 12541005]
110.
Eikeseth S, Smith T, Jahr E, et al. Intensive behavioral treatment at school for 4- to 7-year-old children with autism. A 1-year comparison controlled study. Behav Modif. 2002 Jan;26(1):49–68. [PubMed: 11799654]
111.
Boyd RD, Corley MJ. Outcome survey of early intensive behavioral intervention for young children with autism in a community setting. Autism. 2001 Dec;5(4):430–441. [PubMed: 11777258]
112.
Gabriels RL, Hill DE, Pierce RA, et al. Predictors of treatment outcome in young children with autism: a retrospective study. Autism. 2001 Dec;5(4):407–429. [PubMed: 11777257]
113.
Mudford OC, Martin NT, Eikeseth S, et al. Parent-managed behavioral treatment for preschool children with autism: some characteristics of UK programs. Res Dev Disabil. 2001 05-06;22(3):173–182. [PubMed: 11380057]
114.
Smith T, Groen AD, Wynn JW. Randomized trial of intensive early intervention for children with pervasive developmental disorder. Am J Ment Retard. 2000 Jul;105(4):269–85. [PubMed: 10934569]
115.
Harris SL, Handleman JS. Age and IQ at intake as predictors of placement for young children with autism: a four- to six-year follow-up. J Autism Dev Disord. 2000 Apr;30(2):137–142. [PubMed: 10832778]
116.
Anan RM, Warner LJ, McGillivary JE, et al. Group Intensive Family Training (GIFT) for preschoolers with autism spectrum disorders. Behavioral Interventions. 2008 Jul;23(3):165–180.
117.
Baker-Ericzen MJ, Stahmer AC, Burns A. Child Demographics Associated With Outcomes in a Community-Based Pivotal Response Training Program. Journal of Positive Behavior Interventions. 2007 Win;9(1):52–60.
118.
Dillenburger K, Keenan M, Gallagher S, et al. Parent education and home-based behaviour analytic intervention: An examination of parents’ perceptions of outcome. Journal of Intellectual & Developmental Disability. 2004 Jun;29(2):119–130.
119.
Arick JR, Young HE, Falco RA, et al. Designing an outcome study to monitor the progress of students with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities. 2003 Sum;18(2):75–87.
120.
Stahmer AC, Gist K. The effects of an accelerated parent education program on technique mastery and child outcome. Journal of Positive Behavior Interventions. 2001 Spr;3(2):75–82.
121.
Luiselli JK, Cannon BOM, Ellis JT, et al. Home-based behavioral interventions for young children with autism/pervasive developmental disorder: A preliminary evaluation of outcome in relation to child age and intensity of service delivery. Autism. 2000 Dec;4(4):426–438.
122.
Perry A, Cummings A, Geier JD, et al. Effectiveness of Intensive Behavioral Intervention in a Large, Community-Based Program. Research in Autism Spectrum Disorders. 2008 Oct;2(4):621–642.
123.
Gabriels RL, Ivers BJ, Hill DE, et al. Stability of Adaptive Behaviors in Middle-School Children with Autism Spectrum Disorders. Research in Autism Spectrum Disorders. 2007 10-12;1(4):291–303.
124.
Zachor DA, Ben-Itzchak E, Rabinovich AL, et al. Change in Autism Core Symptoms with Early Intervention: predictors and outcomes. Research in Autism Spectrum Disorders. 2009;3:967–976.
125.
Zachor DA, Ben-Itzchak E, Rabinovich AL, et al. Change in autism core symptoms with intervention. Research in Autism Spectrum Disorders. 1(4):304–317. [Cross Ref]
126.
Hayward D, Eikeseth S, Gale C, et al. Assessing progress during treatment for young children with autism receiving intensive behavioural interventions. Autism. 2009 Nov;13(6):613–633. [PubMed: 19933766]
127.
Granpeesheh D, Tarbox J, Dixon DR, et al. Retrospective analysis of clinical records in 38 cases of recovery from autism. Ann Clin Psychiatry. 2009 10-12;21(4):195–204. [PubMed: 19917210]
128.
Keen D, Rodger S, Doussin K, et al. A pilot study of the effects of a social-pragmatic intervention on the communication and symbolic play of children with autism. Autism. 2007 Jan;11(1):63–71. [PubMed: 17175574]
129.
Howard JS, Sparkman CR, Cohen HG, et al. A comparison of intensive behavior analytic and eclectic treatments for young children with autism. Res Dev Disabil. 2005 07-08;26(4):359–83. [PubMed: 15766629]
130.
Farrell P, Trigonaki N, Webster D. An exploratory evaluation of two early intervention programmes for young children with autism. Educational and Child Psychology. 2005;22(4):29–40.
131.
Bibby P, Eikeseth S, Martin NT, et al. Progress; and outcomes for children with autism receiving parent-managed intensive interventions. Res Dev Disabil. 2002 01-02;23(1):81–104. [PubMed: 12071397]
132.
Eikeseth S, Hayward D, Gale C, et al. Intensity of Supervision and Outcome for Preschool Aged Children Receiving Early and Intensive Behavioral Interventions: A Preliminary Study. Research in Autism Spectrum Disorders. 2009 Jan;3(1):67–73.
133.
Eikeseth S, Smith T, Jahr E, et al. Outcome for children with autism who began intensive behavioral treatment between ages 4 and 7: a comparison controlled study. Behav Modif. 2007 May;31(3):264–278. [PubMed: 17438342]
134.
Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Dev Disord. 2009 May;39(5):693–705. [PMC free article: PMC2922918] [PubMed: 19082876]
135.
Lopata C, Thomeer ML, Volker MA, et al. Effectiveness of a manualized summer social treatment program for high-functioning children with autism spectrum disorders. J Autism Dev Disord. 2008 May;38(5):890–904. [PubMed: 18058012]
136.
Lopata C, Thomeer ML, Volker MA, et al. Effectiveness of a Cognitive-Behavioral Treatment on the Social Behaviors of Children With Asperger Disorder. Focus on Autism and Other Developmental Disabilities. 2006 Win;21(4):237–244.
137.
Bauminger N. Brief report: individual social-multi-modal intervention for HFASD. J Autism Dev Disord. 2007 Sep;37(8):1593–1604. [PubMed: 17072753]
138.
Bauminger N. Brief report: group social-multimodal intervention for HFASD. J Autism Dev Disord. 2007 Sep;37(8):1605–1615. [PubMed: 17072752]
139.
Solomon M, Goodlin-Jones BL, Anders TF. A social adjustment enhancement intervention for high functioning autism, Asperger’s syndrome, and pervasive developmental disorder NOS. J Autism Dev Disord. 2004 Dec;34(6):649–668. [PubMed: 15679185]
140.
Cotugno AJ. Social competence and social skills training and intervention for children with Autism Spectrum Disorders. J Autism Dev Disord. 2009 Sep;39(9):1268–77. [PubMed: 19365716]
141.
Frankel F, Myatt R, Sugar C, et al. A Randomized Controlled Study of Parent-assisted Children’s Friendship Training with Children having Autism Spectrum Disorders. J Autism Dev Disord. 2010 Jan 8 [PMC free article: PMC2890979] [PubMed: 20058059]
142.
Tyminski RF, Moore PJ. The impact of group psychotherapy on social development in children with pervasive development disorders. International Journal of Group Psychotherapy. 2008 Jul;58(3):363–379. [PubMed: 18573027]
143.
Owens G, Granader Y, Humphrey A, et al. LEGO therapy and the social use of language programme: an evaluation of two social skills interventions for children with high functioning autism and Asperger Syndrome. J Autism Dev Disord. 2008 Nov;38(10):1944–1957. [PubMed: 18566882]
144.
Gevers C, Clifford P, Mager M, et al. Brief report: A theory-of-mind-based social-cognition training program for school-aged children with pervasive developmental disorders: an open study of its effectiveness. J Autism Dev Disord. 2006 May;36(4):567–571. [PubMed: 16586154]
145.
Quirmbach LM, Lincoln AJ, Feinberg-Gizzo MJ, et al. Social stories: mechanisms of effectiveness in increasing game play skills in children diagnosed with autism spectrum disorder using a pretest posttest repeated measures randomized control group design. J Autism Dev Disord. 2009 Feb;39(2):299–321. [PubMed: 18704672]
146.
Beaumont R, Sofronoff K. A multi-component social skills intervention for children with Asperger syndrome: the Junior Detective Training Program. J Child Psychol Psychiatry. 2008 Jul;49(7):743–753. [PubMed: 18503531]
147.
Whitaker P. Fostering Communication and Shared Play between Mainstream Peers and Children with Autism: Approaches, Outcomes and Experiences. British Journal of Special Education. 2004 Dec;31(4):215–222.
148.
Legoff DB, Sherman M. Long-Term Outcome of Social Skills Intervention Based on Interactive LEGO[C] Play. Autism: The International Journal of Research & Practice. 2006;10(4):317–329. [PubMed: 16908476]
149.
Kroeger KA, Schultz JR, Newsom C. A Comparison of Two Group-Delivered Social Skills Programs for Young Children with Autism. Journal of Autism and Developmental Disorders. 2007 May;37(5):808–817. [PubMed: 16927011]
150.
McGinnis E, Goldsten A. Skillstreaming the Elementary School Child: New Strategies and Perspectives for Teaching Prosocial Skills. Champaign, IL: Research Press; 1997.
151.
Gray C, Garand J. Social Stories: Improving Responses of Students with Autism with Accurate Social Information. Focus on Autistic Behavior. 1993;8:1–10.
152.
Golan O, Ashwin E, Granader Y, et al. Enhancing Emotion Recognition in Children with Autism Spectrum Conditions: An Intervention Using Animated Vehicles with Real Emotional Faces. Journal of Autism and Developmental Disorders. 2010 Mar;40(3):269–279. [PubMed: 19763807]
153.
Whittingham K, Sofronoff K, Sheffield J, et al. Stepping Stones Triple P: An RCT of a Parenting Program with Parents of a Child Diagnosed with an Autism Spectrum Disorder. Journal of Abnormal Child Psychology. 2009 May;37(4):469–480. [PubMed: 19023654]
154.
Whittingham K, Sofronoff K, Sheffield J, et al. Do Parental Attributions Affect Treatment Outcome in a Parenting Program? An Exploration of the Effects of Parental Attributions in an RCT of Stepping Stones Triple P for the ASD Population. Research in Autism Spectrum Disorders. 2009 Jan;3(1):129–144.
155.
Kasari C, Paparella T, Freeman S, et al. Language outcome in autism: randomized comparison of joint attention and play interventions. J Consult Clin Psychol. 2008 Feb;76(1):125–137. [PubMed: 18229990]
156.
Kasari C, Freeman S, Paparella T. Joint attention and symbolic play in young children with autism: a randomized controlled intervention study. J Child Psychol Psychiatry. 2006 Jun;47(6):611–620. [PubMed: 16712638]
157.
Gulsrud AC, Kasari C, Freeman S, et al. Children with autism’s response to novel stimuli while participating in interventions targeting joint attention or symbolic play skills. Autism. 2007 Nov;11(6):535–546. [PubMed: 17947289]
158.
Wong CS, Kasari C, Freeman S, et al. The Acquisition and Generalization of Joint Attention and Symbolic Play Skills in Young Children with Autism. Research and Practice for Persons with Severe Disabilities (RPSD) 2007 Sum;32(2):101–109.
159.
Gutstein SE, Burgess AF, Montfort K. Evaluation of the relationship development intervention program. Autism. 2007 Sep;11(5):397–411. [PubMed: 17942454]
160.
Solomon R, Necheles J, Ferch C, et al. Pilot Study of a Parent Training Program for Young Children with Autism: The PLAY Project Home Consultation Program. Autism: The International Journal of Research and Practice. 2007;11(3):205–224. [PubMed: 17478575]
161.
Solomon M, Ono M, Timmer S, et al. The effectiveness of parent-child interaction therapy for families of children on the autism spectrum. J Autism Dev Disord. 2008 Oct;38(9):1767–1776. [PubMed: 18401693]
162.
Vorgraft Y, Farbstein I, Spiegel R, et al. Retrospective evaluation of an intensive method of treatment for children with pervasive developmental disorder. Autism. 2007 Sep;11(5):413–424. [PubMed: 17942455]
163.
Field T, Sanders C, Nadel J. Children with autism display more social behaviors after repeated imitation sessions. Autism. 2001 Sep;5(3):317–323. [PubMed: 11708590]
164.
Heimann M, Laberg KE, Nordoen B. Imitative Interaction Increases Social Interest and Elicited Imitation in Non-verbal Children with Autism. Infant and Child Development. Special Issue: Imitation and Socio-Emotional Processes: Implications for Communicative Development and Interventions. 2006 05-06;15(3):297–309.
165.
Escalona A, Field T, Nadel J, et al. Brief report: Imitation effects on children with autism. Journal of Autism and Developmental Disorders. 2002 Apr;32(2):141–144. [PubMed: 12058842]
166.
Mahoney G, Perales F. Relationship-focused early intervention with children with pervasive developmental disorders and other disabilities: a comparative study. J Dev Behav Pediatr. 2005 Apr;26(2):77–85. [PubMed: 15827458]
167.
Gulsrud AC, Jahromi LB, Kasari C. The Co-Regulation of Emotions between Mothers and Their Children with Autism. Journal of Autism and Developmental Disorders. 2010 Feb;40(2):227–237. [PMC free article: PMC2810360] [PubMed: 19714458]
168.
Sofronoff K, Attwood T, Hinton S, et al. A randomized controlled trial of a cognitive behavioural intervention for anger management in children diagnosed with Asperger syndrome. J Autism Dev Disord. 2007 Aug;37(7):1203–1214. [PubMed: 17082978]
169.
Sofronoff K, Attwood T, Hinton S. A randomised controlled trial of a CBT intervention for anxiety in children with Asperger syndrome. J Child Psychol Psychiatry. 2005 Nov;46(11):1152–1160. [PubMed: 16238662]
170.
Wood JJ, Drahota A, Sze K, et al. Cognitive Behavioral Therapy for Anxiety in Children with Autism Spectrum Disorders: A Randomized, Controlled Trial. Journal of Child Psychology and Psychiatry. 2009 Mar;50(3):224–234. [PMC free article: PMC4231198] [PubMed: 19309326]
171.
Wood JJ, Drahota A, Sze K, et al. Brief Report: Effects of Cognitive Behavioral Therapy on Parent-Reported Autism Symptoms in School-Age Children with High-Functioning Autism. Journal of Autism and Developmental Disorders. 2009 Nov;39(11):1608–1612. [PMC free article: PMC2759867] [PubMed: 19562475]
172.
Parent training for children with pervasive developmental disorders: A multi-site feasibility trial. Behavioral Interventions. 2007 Jul;22(3):179–199.
173.
Grey IM, Honan R, McClean B, et al. Evaluating the effectiveness of teacher training in Applied Behaviour Analysis. J Intellect Disabil. 2005 Sep;9(3):209–227. [PubMed: 16144826]
174.
Sofronoff K, Leslie A, Brown W. Parent management training and Asperger syndrome: a randomized controlled trial to evaluate a parent based intervention. Autism. 2004 Sep;8(3):301–317. [PubMed: 15358872]
175.
Sofronoff K, Farbotko M. The effectiveness of parent management training to increase self-efficacy in parents of children with Asperger syndrome. Autism. 2002 Sep;6(3):271–286. [PubMed: 12212918]
176.
Sofronoff K. A Cognitive Behaviour Therapy intervention for anxiety in children with Asperger’s syndrome. Good Autism Practice. 2003;4:2–8.
177.
Aman MG, McDougle CJ, Scahill L, et al. Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial. J Am Acad Child Adolesc Psychiatry. 2009 Oct 23 [PMC free article: PMC3142923] [PubMed: 19858761]
178.
Vismara LA, Young GS, Stahmer AC, et al. Dissemination of Evidence-Based Practice: Can We Train Therapists from a Distance? Journal of Autism and Developmental Disorders. 2009 Dec;39(12):1636–1651. [PMC free article: PMC2777219] [PubMed: 19582564]
179.
Heinrich H, Gevensleben H, Strehl U. Annotation: neurofeedback - train your brain to train behaviour. J Child Psychol Psychiatry. 2007 Jan;48(1):3–16. [PubMed: 17244266]
180.
Wiggs L, France K. Behavioural treatments for sleep problems in children and adolescents with physical illness, psychological problems or intellectual disabilities. Sleep Med Rev. 2000 Jun;4(3):299–314. [PubMed: 12531171]
181.
Jarusiewicz B. Efficacy of Neurofeedback for Children in the Autistic Spectrum: A Pilot Study. Journal of Neurotherapy. 2002;6(4):39–49.
182.
Coben R, Padolsky I. Assessment-guided neurofeedback for autistic spectrum disorder. Journal of Neurotherapy. 2007;11(1):5–23.
183.
Reed HE, McGrew SG, Artibee K, et al. Parent-based sleep education workshops in autism. J Child Neurol. 2009 Aug;24(8):936–945. [PMC free article: PMC3786206] [PubMed: 19491110]
184.
Mesibov GB, Shea V. The TEACCH program in the era of evidence-based practice. J Autism Dev Disord. 2010 May;40(5):570–9. [PubMed: 19937103]
185.
Panerai S, Zingale M, Trubia G, et al. Special education versus inclusive education: the role of the TEACCH program. J Autism Dev Disord. 2009 Jun;39(6):874–882. [PubMed: 19205860]
186.
Probst P, Leppert T. Brief report: outcomes of a teacher training program for autism spectrum disorders. J Autism Dev Disord. 2008 Oct;38(9):1791–1796. [PubMed: 18369717]
187.
Tsang SK, Shek DT, Lam LL, et al. Brief report: application of the TEACCH program on Chinese pre-school children with autism--Does culture make a difference? J Autism Dev Disord. 2007 Feb;37(2):390–6. [PubMed: 16906461]
188.
Mukaddes NM, Kaynak FN, Kinali G, et al. Psychoeducational treatment of children with autism and reactive attachment disorder. Autism. 2004 Mar;8(1):101–109. [PubMed: 15070550]
189.
Moore M, Calvert S. Brief report: vocabulary acquisition for children with autism: teacher or computer instruction. J Autism Dev Disord. 2000 Aug;30(4):359–362. [PubMed: 11039862]
190.
Tjus T, Heimann M, Nelson KE. Interaction patterns between children and their teachers when using a specific multimedia and communication strategy: observations from children with autism and mixed intellectual disabilities. Autism. 2001 Jun;5(2):175–187. [PubMed: 11706865]
191.
Greenberg JH, Martinez RC. Starting Off on the Right Foot: One Year of Behavior Analysis in Practice and Relative Cost. International Journal of Behavioral Consultation and Therapy. 2008;4(2):212–226.
192.
Reed P, Osborne LA, Corness M. The Real-World Effectiveness of Early Teaching Interventions for Children with Autism Spectrum Disorder. Exceptional Children. 2007 Sum;73(4):417–433.
193.
Stahmer AC, Ingersoll B. Inclusive Programming for Toddlers with Autism Spectrum Disorders: Outcomes from the Children’s Toddler School. Journal of Positive Behavior Interventions. 2004;6(2):67–82.
194.
Rickards AL, Walstab JE, Wright-Rossi RA, et al. A randomized, controlled trial of a home-based intervention program for children with autism and developmental delay. J Dev Behav Pediatr. 2007 Aug;28(4):308–316. [PubMed: 17700083]
195.
Magiati I, Charman T, Howlin P. A two-year prospective follow-up study of community-based early intensive behavioural intervention and specialist nursery provision for children with autism spectrum disorders. J Child Psychol Psychiatry. 2007 Aug;48(8):803–812. [PubMed: 17683452]
196.
Osborne LA, McHugh L, Saunders J, et al. Parenting stress reduces the effectiveness of early teaching interventions for autistic spectrum disorders. J Autism Dev Disord. 2008 Jul;38(6):1092–1103. [PubMed: 18027079]
197.
Salt J, Shemilt J, Sellars V, et al. The Scottish Centre for autism preschool treatment programme. II: The results of a controlled treatment outcome study. Autism. 2002 Mar;6(1):33–46. [PubMed: 11918108]
198.
Rickards AL, Walstab JE, Wright-Rossi RA, et al. One-year follow-up of the outcome of a randomized controlled trial of a home-based intervention programme for children with autism and developmental delay and their families. Child Care Health Dev. 2009 Sep;35(5):593–602. [PubMed: 19508318]
199.
Reed P, Osborne LA, Corness M. Effectiveness of Special Nursery Provision for Children with Autism Spectrum Disorders. Autism: The International Journal of Research and Practice. 2010;14(1):67–82. [PubMed: 20124504]
200.
Whalen C, Moss D, Ilan AB, et al. Efficacy of TeachTown: Basics computer-assisted intervention for the Intensive Comprehensive Autism Program in Los Angeles Unified School District. Autism. 2010 May;14(3):179–97. [PubMed: 20484002]
201.
Aman MG, Hollway JA, McDougle CJ, et al. Cognitive effects of risperidone in children with autism and irritable behavior. J Child Adolesc Psychopharmacol. 2008 Jun;18(3):227–236. [PMC free article: PMC2935828] [PubMed: 18582177]
202.
Aman MG, Arnold LE, McDougle CJ, et al. Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869–884. [PubMed: 16379507]
203.
Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry. 2005 Jul;162(7):1361–1369. [PubMed: 15994720]
204.
McDougle CJ, Scahill L, Aman MG, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005 Jun;162(6):1142–1148. [PubMed: 15930063]
205.
Martin A, Scahill L, Anderson GM, et al. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. Am J Psychiatry. 2004 Jun;161(6):1125–1127. [PubMed: 15169706]
206.
McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002 Aug 1;347(5):314–321. [PubMed: 12151468]
207.
Arnold LE, Vitiello B, McDougle C, et al. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. J Am Acad Child Adolesc Psychiatry. 2003 Dec;42(12):1443–1450. [PubMed: 14627879]
208.
Williams SK, Scahill L, Vitiello B, et al. Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):431–439. [PubMed: 16601648]
209.
Anderson GM, Scahill L, McCracken JT, et al. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry. 2007 Feb 15;61(4):545–550. [PubMed: 16730335]
210.
Pandina GJ, Bossie CA, Youssef E, et al. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord. 2007 Feb;37(2):367–373. [PubMed: 17019624]
211.
Shea S, Turgay A, Carroll A, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004 Nov;114(5):e634–41. [PubMed: 15492353]
212.
Nagaraj R, Singhi P, Malhi P. Risperidone in children with autism: randomized, placebo-controlled, double-blind study. J Child Neurol. 2006 Jun;21(6):450–5. [PubMed: 16948927]
213.
Masi G, Cosenza A, Mucci M, et al. A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone. J Clin Psychiatry. 2003 Sep;64(9):1039–1047. [PubMed: 14628979]
214.
Correia CT, Almeida JP, Santos PE, et al. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions. Pharmacogenomics J. 2009 Dec 8 [PubMed: 19997080]
215.
Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1110–1109. [PubMed: 19797985]
216.
Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009 Dec;124(6):1533–1540. [PubMed: 19948625]
217.
Akhondzadeh S, Erfani S, Mohammadi MR, et al. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial. J Clin Pharm Ther. 2004 Apr;29(2):145–50. [PubMed: 15068403]
218.
Scahill L, McDougle CJ, Williams SK, et al. Children’s Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1114–1123. [PubMed: 16926619]
219.
Anderson LT, Campbell M, Grega DM, et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry. 1984 Oct;141(10):1195–1202. [PubMed: 6385731]
220.
Hollander E, Phillips A, Chaplin W, et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005 Mar;30(3):582–589. [PubMed: 15602505]
221.
DeLong GR, Ritch CR, Burch S. Fluoxetine response in children with autistic spectrum disorders: correlation with familial major affective disorder and intellectual achievement. Dev Med Child Neurol. 2002 Oct;44(10):652–659. [PubMed: 12418789]
222.
King BH, Hollander E, Sikich L, et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009 Jun;66(6):583–590. [PMC free article: PMC4112556] [PubMed: 19487623]
223.
Owley T, Brune CW, Salt J, et al. A pharmacogenetic study of escitalopram in autism spectrum disorders. Autism Res. 2010 Feb;3(1):1–7. [PMC free article: PMC2937270] [PubMed: 20020537]
224.
Henry CA, Steingard R, Venter J, et al. Treatment outcome and outcome associations in children with pervasive developmental disorders treated with selective serotonin reuptake inhibitors: a chart review. J Child Adolesc Psychopharmacol. 2006 02-04;16(1–2):187–195. [PubMed: 16553539]
225.
Geller DA, Biederman J, Stewart SE, et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003 Nov;160(11):1919–1928. [PubMed: 14594734]
226.
March JS, Biederman J, Wolkow R, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA. 1998 Nov 25;280(20):1752–176. [PubMed: 9842950]
227.
Owley T, Walton L, Salt J, et al. An open-label trial of escitalopram in pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 2005 Apr;44(4):343–348. [PubMed: 15782081]
228.
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005 Nov;62(11):1266–1274. [PubMed: 16275814]
229.
Posey DJ, Aman MG, McCracken JT, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry. 2007 Feb 15;61(4):538–544. [PubMed: 17276750]
230.
Jahromi LB, Kasari CL, McCracken JT, et al. Positive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity. Journal of Autism and Developmental Disorders. 2009 Mar;39(3):395–404. [PMC free article: PMC4374624] [PubMed: 18752063]
231.
Nickels K, Katusic SK, Colligan RC, et al. Stimulant medication treatment of target behaviors in children with autism: a population-based study. J Dev Behav Pediatr. 2008 Apr;29(2):75–81. [PMC free article: PMC2585372] [PubMed: 18478626]
232.
Posey DJ, Puntney JI, Sasher TM, et al. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol. 2004 Summer;14(2):233–241. [PubMed: 15319020]
233.
Stigler KA, Desmond LA, Posey DJ, et al. A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2004 Spring;14(1):49–56. [PubMed: 15142391]
234.
Levy SE, Souders MC, Wray J, et al. Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin. Arch Dis Child. 2003 Aug;88(8):731–736. [PMC free article: PMC1719589] [PubMed: 12876177]
235.
Molloy CA, Manning-Courtney P, Swayne S, et al. Lack of benefit of intravenous synthetic human secretin in the treatment of autism. J Autism Dev Disord. 2002 Dec;32(6):545–551. [PubMed: 12553591]
236.
Unis AS, Munson JA, Rogers SJ, et al. A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism. J Am Acad Child Adolesc Psychiatry. 2002 Nov;41(11):1315–1321. [PubMed: 12410073]
237.
Owley T, McMahon W, Cook EH, et al. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1293–1299. [PubMed: 11699803]
238.
Roberts W, Weaver L, Brian J, et al. Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. Pediatrics. 2001 May;107(5):E71. [PubMed: 11331721]
239.
Coniglio SJ, Lewis JD, Lang C, et al. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. J Pediatr. 2001 May;138(5):649–655. [PubMed: 11343038]
240.
Dunn-Geier J, Ho HH, Auersperg E, et al. Effect of secretin on children with autism: a randomized controlled trial. Dev Med Child Neurol. 2000 Dec;42(12):796–802. [PubMed: 11132252]
241.
Chez MG, Buchanan CP, Bagan BT, et al. Secretin and autism: a two-part clinical investigation. J Autism Dev Disord. 2000 Apr;30(2):87–94. [PubMed: 10832772]
242.
Dosman CF, Brian JA, Drmic IE, et al. Children with autism: effect of iron supplementation on sleep and ferritin. Pediatr Neurol. 2007 Mar;36(3):152–158. [PubMed: 17352947]
243.
Mousain-Bosc M, Roche M, Polge A, et al. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. Magnes Res. 2006 Mar;19(1):53–62. [PubMed: 16846101]
244.
Andersen IM, Kaczmarska J, McGrew SG, et al. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. 2008 May;23(5):482–485. [PubMed: 18182647]
245.
Evangeliou A, Vlachonikolis I, Mihailidou H, et al. Application of a ketogenic diet in children with autistic behavior: pilot study. J Child Neurol. 2003 Feb;18(2):113–118. [PubMed: 12693778]
246.
Meguid NA, Atta HM, Gouda AS, et al. Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clin Biochem. 2008 Sep;41(13):1044–8. [PubMed: 18582451]
247.
Chez MG, Buchanan CP, Aimonovitch MC, et al. Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol. 2002 Nov;17(11):833–837. [PubMed: 12585724]
248.
Kern JK, Miller VS, Cauller PL, et al. Effectiveness of N, N-dimethylglycine in autism and pervasive developmental disorder. J Child Neurol. 2001 Mar;16(3):169–173. [PubMed: 11305684]
249.
Munasinghe SA, Oliff C, Finn J, et al. Digestive Enzyme Supplementation for Autism Spectrum Disorders: A Double-Blind Randomized Controlled Trial. J Autism Dev Disord. 2010 Mar 5 [PubMed: 20204691]
250.
Adams JB, Baral M, Geis E, et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A--medical results. BMC Clin Pharmacol. 2009;9:16. [PMC free article: PMC2774660] [PubMed: 19852789]
251.
King BH, Wright DM, Handen BL, et al. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):658–665. [PubMed: 11392343]
252.
Akhondzadeh S, Tajdar H, Mohammadi MR, et al. A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder. Child Psychiatry Hum Dev. 2008 Sep;39(3):237–245. [PubMed: 17929164]
253.
Akhondzadeh S, Fallah J, Mohammadi M-R, et al. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2010 Feb;34(1):32–36. [PubMed: 19772883]
254.
Rossignol DA, Rossignol LW, Smith S, et al. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr. 2009;9:21. [PMC free article: PMC2662857] [PubMed: 19284641]
255.
Adams JB, Baral M, Geis E, et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. BMC Clin Pharmacol. 2009;9:17. [PMC free article: PMC2770991] [PubMed: 19852790]
256.
Chez MG, Aimonovitch M, Buchanan T, et al. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol. 2004 Mar;19(3):165–169. [PubMed: 15119476]
257.
Chez MG, Buchanan TM, Becker M, et al. Donepezil hydrochloride: A double-blind study in autistic children. Journal of Pediatric Neurology. 2003 10-12;1(2):83–88.
258.
Yoder PJ. Predicting lexical density growth rate in young children with autism spectrum disorders. Am J Speech Lang Pathol. 2006 Nov;15(4):378–388. [PubMed: 17102148]
259.
Yoder P, Stone WL. A randomized comparison of the effect of two prelinguistic communication interventions on the acquisition of spoken communication in preschoolers with ASD. J Speech Lang Hear Res. 2006 Aug;49(4):698–711. [PubMed: 16908870]
260.
Yoder P, Stone WL. Randomized comparison of two communication interventions for preschoolers with autism spectrum disorders. J Consult Clin Psychol. 2006 Jun;74(3):426–435. [PubMed: 16822100]
261.
Yoder PJ, Lieberman RG. Brief Report: Randomized Test of the Efficacy of Picture Exchange Communication System on Highly Generalized Picture Exchanges in Children with ASD. J Autism Dev Disord. 2009 Nov 11 [PMC free article: PMC4136745] [PubMed: 19904596]
262.
Carr D, Felce J. The effects of PECS teaching to Phase III on the communicative interactions between children with autism and their teachers. J Autism Dev Disord. 2007 Apr;37(4):724–737. [PubMed: 17006780]
263.
Howlin P, Gordon RK, Pasco G, et al. The effectiveness of Picture Exchange Communication System (PECS) training for teachers of children with autism: a pragmatic, group randomised controlled trial. J Child Psychol Psychiatry. 2007 May;48(5):473–481. [PubMed: 17501728]
264.
Magiati I, Howlin P. A pilot evaluation study of the Picture Exchange Communication System (PECS) for children with autistic spectrum disorders. Autism. 2003 Sep;7(3):297–320. [PubMed: 14516062]
265.
Carr D, Felce J. Teaching picture-to-object relations in picture-based requesting by children with autism: a comparison between error prevention and error correction teaching procedures. J Intellect Disabil Res. 2008 Apr;52(Pt 4):309–317. [PubMed: 18339093]
266.
Fazlioglu Y, Baran G. A sensory integration therapy program on sensory problems for children with autism. Percept Mot Skills. 2008 Apr;106(2):415–422. [PubMed: 18556898]
267.
Jung KE, Lee HJ, Lee YS, et al. Efficacy of sensory integration treatment based on virtual reality - Tangible interaction for children with autism. Annual Review of CyberTherapy and Telemedicine. 2006;4:45–49.
268.
Jung K-E, Lee H-J, Lee Y-S, et al. The Application of a Sensory Integration Treatment Based on Virtual Reality-Tangible Interaction for Children with Autistic Spectrum Disorder. PsychNology Journal. Special Issue: Emerging Trends in Cybertherapy. 2006;4(2):145–159.
269.
Mudford OC, Cross BA, Breen S, et al. Auditory integration training for children with autism: no behavioral benefits detected. Am J Ment Retard. 2000 Mar;105(2):118–129. [PubMed: 10755175]
270.
Corbett BA, Shickman K, Ferrer E. Brief report: the effects of Tomatis sound therapy on language in children with autism. J Autism Dev Disord. 2008 Mar;38(3):562–566. [PubMed: 17610057]
271.
Kim J, Wigram T, Gold C. The effects of improvisational music therapy on joint attention behaviors in autistic children: a randomized controlled study. J Autism Dev Disord. 2008 Oct;38(9):1758–1766. [PubMed: 18592368]
272.
Sams MJ, Fortney EV, Willenbring S. Occupational therapy incorporating animals for children with autism: A pilot investigation. Am J Occup Ther. 2006 05-06;60(3):268–274. [PubMed: 16776394]
273.
Carmody DP, Kaplan M, Gaydos AM. Spatial orientation adjustments in children with autism in Hong Kong. Child Psychiatry Hum Dev. 2001 Spring;31(3):233–247. [PubMed: 11196013]
274.
Hartshorn K, Olds L, Field T, et al. Creative movement therapy benefits children with autism. Early Child Development and Care. 2001;166:1–5.
275.
Ludlow AK, Wilkins AJ, Heaton P. Colored Overlays Enhance Visual Perceptual Performance in Children with Autism Spectrum Disorders. Research in Autism Spectrum Disorders. 2008 07-09;2(3):498–515.
276.
Bass MM, Duchowny CA, Llabre MM. The effect of therapeutic horseback riding on social functioning in children with autism. J Autism Dev Disord. 2009 Sep;39(9):1261–1267. [PubMed: 19350376]
277.
Ludlow AK, Wilkins AJ, Heaton P. The effect of coloured overlays on reading ability in children with autism. J Autism Dev Disord. 2006 May;36(4):507–516. [PubMed: 16598434]
278.
Laud RB, Girolami PA, Boscoe JH, et al. Treatment outcomes for severe feeding problems in children with autism spectrum disorder. Behav Modif. 2009 Sep;33(5):520–536. [PubMed: 19748900]
279.
Pan CY. Effects of water exercise swimming program on aquatic skills and social behaviors in children with autism spectrum disorders. Autism. 2010 Jan;14(1):9–28. [PubMed: 20124502]
280.
Allam H, ElDine NG, Helmy G. Scalp acupuncture effect on language development in children with autism: a pilot study. J Altern Complement Med. 2008 Mar;14(2):109–114. [PubMed: 18315511]
281.
Chan AS, Cheung MC, Sze SL, et al. Seven-star needle stimulation improves language and social interaction of children with autistic spectrum disorders. Am J Chin Med. 2009;37(3):495–504. [PubMed: 19606510]
282.
Silva LM, Ayres R, Schalock M. Outcomes of a pilot training program in a qigong massage intervention for young children with autism. Am J Occup Ther. 2008 09-10;62(5):538–546. [PubMed: 18826014]
283.
Silva LM, Cignolini A, Warren R, et al. Improvement in sensory impairment and social interaction in young children with autism following treatment with an original Qigong massage methodology. Am J Chin Med. 2007;35(3):393–406. [PubMed: 17597498]
284.
Escalona A, Field T, Singer-Strunck R, et al. Brief report: improvements in the behavior of children with autism following massage therapy. J Autism Dev Disord. 2001 Oct;31(5):513–516. [PubMed: 11794416]
285.
Silva LM, Schalock M, Ayres R, et al. Qigong massage treatment for sensory and self-regulation problems in young children with autism: a randomized controlled trial. Am J Occup Ther. 2009 07-08;63(4):423–432. [PubMed: 19708471]
286.
Piravej K, Tangtrongchitr P, Chandarasiri P, et al. Effects of Thai traditional massage on autistic children’s behavior. J Altern Complement Med. 2009 Dec;15(12):1355–1361. [PubMed: 20001837]
287.
Sallows GO, Graupner TD. Intensive behavioral treatment for children with autism: four-year outcome and predictors. Am J Ment Retard. 2005 Nov;110(6):417–438. [PubMed: 16212446]
288.
Bryson SE, Zwaigenbaum L, Brian J, et al. A prospective case series of high-risk infants who developed autism. J Autism Dev Disord. 2007 Jan;37(1):12–24. [PubMed: 17211728]
289.
Cross S, Kim SJ, Weiss LA, et al. Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology. 2008 Jan;33(2):353–360. [PMC free article: PMC2739682] [PubMed: 17406648]
290.
Dawson G, Rogers S, Munson J, et al. Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model. Pediatrics. 2009 Nov 30 [PMC free article: PMC4951085] [PubMed: 19948568]
291.
Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 2000 Aug 22;55(4):468–479. [PubMed: 10953176]
292.
Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. 1999 Dec;29(6):439–484. [PubMed: 10638459]
293.
Stone WL, Lee EB, Ashford L, et al. Can autism be diagnosed accurately in children under 3 years? J Child Psychol Psychiatry. 1999 Feb;40(2):219–226. [PubMed: 10188704]
294.
Wetherby AM, Woods JJ. Early Social Interaction Project for Children with Autism Spectrum Disorders Beginning in the Second Year of Life: A Preliminary Study. Topics in Early Childhood Special Education. 2006 Sum;26(2):67–82.
295.
McConachie H, Randle V, Hammal D, et al. A controlled trial of a training course for parents of children with suspected autism spectrum disorder. J Pediatr. 2005 Sep;147(3):335–340. [PubMed: 16182672]
296.
Spreckley M, Boyd R. Efficacy of Applied Behavioral Intervention in Preschool Children with Autism for Improving Cognitive, Language, and Adaptive Behavior: A Systematic Review and Meta-analysis. J Pediatr. 2008 Oct 22 [PubMed: 18950798]
297.
Special report: early intensive behavioral intervention based on applied behavior analysis among children with autism spectrum disorders. Technol Eval Cent Asses Program Exec Summ. 2009 Feb;23(9):1–5. [PubMed: 19297806]
298.
Reichow B, Wolery M. Comprehensive Synthesis of Early Intensive Behavioral Interventions for Young Children with Autism Based on the UCLA Young Autism Project Model. Journal of Autism and Developmental Disorders. 2009 Jan;39(1):23–41. [PubMed: 18535894]
299.
Eldevik S, Hastings RP, Hughes JC, et al. Meta-analysis of Early Intensive Behavioral Intervention for children with autism. J Clin Child Adolesc Psychol. 2009 May;38(3):439–450. [PubMed: 19437303]
300.
Mulloy A, Lang R, O’Reilly M, et al. Gluten-Free and Casein-Free Diets in the Treatment of Autism Spectrum Disorders: A Systematic Review. Research in Autism Spectrum Disorders. 2010 07-09;4(3):328–339.
301.
Schlosser RW, Wendt O. Effects of augmentative and alternative communication intervention on speech production in children with autism: a systematic review. Am J Speech Lang Pathol. 2008 Aug;17(3):212–230. [PubMed: 18663107]
302.
Flippin M, Reszka S, Watson LR. Effectiveness of the Picture Exchange Communication System (PECS) on communication and speech for children with autism spectrum disorders: a meta-analysis. Am J Speech Lang Pathol. 2010 May;19(2):178–195. [PubMed: 20181849]
303.
Russo NM, Skoe E, Trommer B, et al. Deficient brainstem encoding of pitch in children with Autism Spectrum Disorders. Clin Neurophysiol. 2008 Aug;119(8):1720–1731. [PMC free article: PMC2536645] [PubMed: 18558508]
304.
Posey DJ, Erickson CA, Stigler KA, et al. The use of selective serotonin reuptake inhibitors in autism and related disorders. J Child Adolesc Psychopharmacol. 2006 02-04;16(1–2):181–186. [PubMed: 16553538]
305.
Levy SE, Hyman SL. Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing. Pediatr Ann. 2003 Oct;32(10):685–691. [PubMed: 14606219]
306.
Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004 Oct 27;292(16):1969–1976. [PubMed: 15507582]
307.
March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004 Aug 18;292(7):807–820. [PubMed: 15315995]
308.
Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008 Dec 25;359(26):2753–2766. [PMC free article: PMC2702984] [PubMed: 18974308]
309.
Davis M, Ressler K, Rothbaum BO, et al. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry. 2006 Aug 15;60(4):369–375. [PubMed: 16919524]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (5.7M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...